Paietta E - Search Results

1

Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group.

Friedenberg WR, Tallman MS, Brodsky I, Paietta E, Rowe JM, Lee SJ, Rowland KM Jr, Schnetzer GW, Reed JC. Friedenberg WR, et al. Among authors: paietta e. Leuk Res. 2004 Aug;28(8):813-9. doi: 10.1016/j.leukres.2003.12.002. Leuk Res. 2004. PMID: 15203279 Clinical Trial.

2

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Among authors: paietta e. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

3

Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.

Wiernik PH, Dutcher JP, Paietta E, Hittelman WN, Vyas R, Strack M, Castaigne S, Degos L, Gallagher RE. Wiernik PH, et al. Among authors: paietta e. Leukemia. 1991 Jun;5(6):504-9. Leukemia. 1991. PMID: 2056773

4

The 5q-- deletion: correlation of breakpoints with the immunophenotype of leukemic blast cells.

Paietta E, Papenhausen P, Gucalp R, Reed J, Wiernik PH. Paietta E, et al. Leukemia. 1987 Dec;1(12):822-4. Leukemia. 1987. PMID: 3695588

5

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Among authors: paietta e. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

6

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: paietta e. Blood. 1995 Aug 15;86(4):1540-7. Blood. 1995. PMID: 7632962 Free article.

7

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.

Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. Paietta E, et al. Leukemia. 1994 Jul;8(7):1108-12. Leukemia. 1994. PMID: 8035602

8

Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L. Wiernik PH, et al. Among authors: paietta e. Leukemia. 1993 Aug;7(8):1236-41. Leukemia. 1993. PMID: 8350624

9

A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Wiernik PH. Paietta E, et al. Leukemia. 1996 Jan;10(1):1-4. Leukemia. 1996. PMID: 8558912 Review. No abstract available.

10

Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.

Bennett JM, Cassileth PA, Paietta E, Rowe JM, Wiernik PH. Bennett JM, et al. Among authors: paietta e. Leukemia. 1996 Aug;10(8):1365. Leukemia. 1996. PMID: 8709645 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page